Department of Physiology and Biophysics and Department of Urology, Cornell University Medical College, New York, New York, USA.
Address correspondence to: Doris Herzlinger, Cornell University Medical College, Physiology and Biophysics D-501, 1300 York Ave., New York, New York 10021-4805, USA. Phone: 212.746.6377; Fax: 212.746.8690; E-mail: firstname.lastname@example.org.
Published February 21, 2011 - More info
Obstructive and nonobstructive forms of hydronephrosis (increased diameter of the renal pelvis and calyces) and hydroureter (dilatation of the ureter) are the most frequently detected antenatal abnormalities, yet the underlying molecular mechanisms are largely undefined. Hedgehog (Hh) proteins control tissue patterning and cell differentiation by promoting GLI-dependent transcriptional activation and by inhibiting the processing of GLI3 to a transcriptional repressor. Genetic mutations that generate a truncated GLI3 protein similar in size to the repressor in humans with Pallister-Hall syndrome (PHS; a disorder whose characteristics include renal abnormalities) and hydroureter implicate Hh-dependent signaling in ureter morphogenesis and function. Here, we determined that Hh signaling controls 2 cell populations required for the initiation and transmission of coordinated ureter contractions. Tissue-specific inactivation of the Hh cell surface effector Smoothened (Smo) in the renal pelvic and upper ureteric mesenchyme resulted in nonobstructive hydronephrosis and hydroureter characterized by ureter dyskinesia. Mutant mice had reduced expression of markers of cell populations implicated in the coordination of unidirectional ureter peristalsis (specifically, Kit and hyperpolarization-activation cation–3 channel [Hcn3]), but exhibited normal epithelial and smooth muscle cell differentiation. Kit deficiency in a mouse model of PHS suggested a pathogenic role for GLI3 repressor in Smo-deficient embryos; indeed, genetic inactivation of Gli3 in Smo-deficient mice rescued their hydronephrosis, hydroureter, Kit and Hcn3 expression, and ureter peristalsis. Together, these data demonstrate that Hh signaling controls Kit and Hcn3 expression and ureter peristalsis.
Jason E. Cain, Epshita Islam, Fiona Haxho, Joshua Blake, Norman D. Rosenblum
Mutations in GLI3, a component of the Sonic Hedgehog (Shh) signaling pathway, cause a variety of human developmental syndromes. In this issue of the JCI, Cain and colleagues show that tightly regulated GLI3 repressor activity is essential for Shh-dependent differentiation of upper urinary tract pacemaker cells and the efficient flow of urine from the kidney to the bladder. These results link defective pacemaker cell differentiation with hydronephrosis and provide a cellular basis for one of the abnormal renal defects observed in humans with the GLI3-linked disease Pallister-Hall syndrome.
The kidney outflow tract carries wastes removed from the systemic circulation by glomerular filtration and tubular secretion to the bladder (1). It is composed of the renal calyces, pelvis, and ureter and has specialized differentiated properties that mediate this essential conduit function. The outflow tract epithelium has an impermeable luminal surface preventing wastes carried in the urine from diffusing back into the systemic circulation. The proximal-to-distal contractions that propagate through the outflow tract smooth muscle coat are essential for propelling urine into the lower urinary tract.
Despite its seemingly simple structure and function, congenital defects localized to the kidney outflow tract are detected in approximately 0.5% of fetuses analyzed by routine antenatal sonography (2). These defects obstruct the flow of urine out of the kidney, causing dilations of the renal pelvis (i.e., hydronephrosis). Although a substantial percentage of fetal hydronephrotic syndromes spontaneously resolve, if severe and persistent, hydronephrosis results in permanent kidney damage and is the major cause of renal failure in infants and children.
The causes of congenital hydronephrosis are various (Figure 1). For example, it can be caused by structural occlusions of the outflow tract as a result of compression by ectopic renal vessels, abnormal insertion of the ureter into the bladder, or overgrowth of the outflow tract epithelium. Alternatively, it can be caused by functional defects in the formation of the outflow tract smooth muscle coat, leading to severely impaired or even absent peristalsis. Finally, hydronephrosis could be caused by defects in the cells that initiate and coordinate outflow tract contraction.
The kidney outflow tract includes the renal calyces, pelvis, and ureter and is highly prone to congenital defects. Abnormalities that severely impair the flow of urine through the outflow tract lead to hydronephrosis and often permanent kidney damage. Known causes of hydronephrosis include outflow tract compression by ectopic renal vessels, structural occlusions intrinsic to the outflow tract, and aberrant outflow tract smooth muscle differentiation that results in aperistaltic ureter segments. The report by Cain et al. (13) shows that hydronephrosis can also be caused by inefficient, dysplastic peristalsis caused by an absence of upper urinary tract pacemakers, the specialized cells that trigger smooth muscle contractions.
Over the past 10 years, several mouse models that develop hydronephrosis during embryonic development have provided insight into the genetic pathways controlling outflow tract formation and function. Targeted deletion of members of the uroplakin gene family, which are selectively expressed by the urothelium, result in structural obstruction as a result of epithelial hyperplasia (3). Proper insertion of the ureter into the bladder wall is essential for the formation of a patent outflow tract, and studies by Mendelsohn’s group demonstrated that this process is dependent on retinoic acid signaling mediated in part by the tyrosine receptor cRet (4). Finally, mouse models that develop hydronephrosis in the absence of any obvious structural occlusions in the outflow tract have led to the identification of several signaling and transcription factors required for outflow tract smooth muscle differentiation and organization, including bone morphogenetic protein 4, Tbx18, Teashirt, and Six1, to name only a few (reviewed in ref. 5). However, mice with conditional inactivation of the calcineurin signaling pathway in the periureteral mesenchyme develop hydronephrosis and renal damage despite the presence of a patent outflow tract, differentiated ureteral epithelium, and well-developed smooth muscle coat (6).
Fundamental scientific studies dating back to the late 1800s provided insight into a possible etiology of hydronephrotic syndromes that could not be explained by either structural occlusion or gross defect in ureteral epithelial or smooth muscle formation. These studies suggested that the efficient flow of urine from the kidney to the bladder is dependent on the presence of specialized myocytes that trigger the coordinated, proximal-to-distal peristaltic waves that propagate through the outflow tract smooth muscle coat (7). These specialized myocytes, called pacemaker cells, elicit spontaneous membrane depolarizations that provide the stimulus for triggering ureteral smooth muscle contraction and play a fundamental role in controlling the frequency and origin of contractile waves in the outflow tract musculature. As in the heart, the outflow tract contains primary pacemakers that trigger contractions at the site of fluid inflow as well as secondary, latent pacemaker activity that can trigger contraction in the event of primary pacemaker failure.
Although the electrophysiological properties of upper urinary tract pacemaker cells have been extensively analyzed, the ion channels and receptors required for their function have remained elusive until recently. Our group has begun to unravel the molecular mechanisms mediating outflow tract pacemaker activity, recently discovering that hyperpolarizing activated cation channels (HCNs) play a fundamental role in triggering outflow tract peristalsis (8). The HCN gene family includes at least 4 members, and HCN2 and HCN4 are essential for mediating cardiac pacemaker activity (9). We found that HCN3 is selectively expressed by cells adjacent to the renal-most edge of the outflow tract musculature, where contractions normally initiate. Furthermore, optical mapping analyses demonstrated that HCN activity is essential for the spontaneous membrane depolarizations that initiate and coordinate outflow tract peristalsis. These data indicate that HCN3 expression marks primary outflow tract pacemaker cells and that these cells are required for outflow tract function. Moreover, our previous studies indicated that c-Kit tyrosine kinase activity is also required for coordinated outflow tract peristalsis in vitro (10). Cells expressing c-Kit are distinct from HCN3+ cells and exhibit spatial distribution and electrophysiological properties consistent with secondary outflow tract pacemakers (10–12). Collectively, these results imply that abnormal expression of c-Kit and HCN in the developing outflow tract can lead to uncoordinated and inefficient outflow tract peristalsis and impaired urine flow into the lower urinary tract. The manuscript included in this issue of JCI by Cain et al. provides strong support for this hypothesis (13).
To understand how abnormal Sonic hedgehog (Shh) signaling in humans causes renal defects, including hydronephrosis, Cain et al. disrupted this signaling pathway in the developing murine outflow tract by a variety of genetic manipulations. Previous studies demonstrated that targeted deletion of Shh in the ureter epithelia beginning at early stages of urinary tract morphogenesis resulted in abnormal outflow tract smooth muscle formation (14). The present studies by Cain et al. demonstrate that Shh signaling is also crucial later in development for the acquisition of coordinated outflow tract smooth muscle contraction (13).
Shh signaling is mediated by transcription factors belonging to the GLI family of transcriptional regulators: GLI1, GLI2, and GLI3. Notably, the GLIs variably activate and repress transcription; in the absence of secreted Shh, the cell surface receptor Patched associates with a second protein, Smoothened, converting GLI3 into a transcriptional repressor. In the presence of Shh, Patched dissociates from Smoothened, and GLI3 — along with GLI2 — activates Shh-dependent transcription (15, 16).
Cain et al. first showed that disruption of Shh signaling by conditional deletion of Smoothened in the urinary tract mesenchyme at midgestation resulted in hydronephrosis and permanent renal damage (13). Smoothened mutant outflow tracts were patent and surrounded by a contraction-competent smooth muscle coat. However, contractions in this mutant outflow tract musculature were uncoordinated and did not efficiently propel urine from the kidney to the bladder. Further analyses demonstrated that Smoothened-deficient mice exhibited wild-type levels of epithelial and smooth muscle differentiation markers. Strikingly, the mutant mice lacked detectable levels of HCN and c-Kit expression. Collectively, these data indicate that the contraction defects and resulting hydronephrosis observed in Smoothened-deficient mice are caused by abnormal pacemaker cell differentiation.
The above findings, combined with the renal defects observed in humans with Pallister-Hall syndrome, suggest that Smoothened may be required for the upregulated expression of HCN and c-Kit via a GLI3-dependent process. To address this, Cain et al. examined outflow tract formation in a murine model of Pallister-Hall syndrome with a targeted mutation in Gli3 (Δ699) that generates truncated protein (13). Homozygous Gli3Δ699 mutant mice developed urinary tract phenotypes that were nearly identical to those observed in mice with conditional Smoothened inactivation, including an absence of c-Kit– and HCN3-expressing cells, uncoordinated peristalsis, and hydronephrosis. Taken together, these data indicate that the acquisition of unidirectional, coordinated peristalsis in the developing outflow tract is dependent on tightly regulated GLI3 repressor activity and provide insight into the etiology of the hydronephrotic syndromes observed in Pallister-Hall patients.
In conclusion, the work of Cain et al. (13), as well as other fundamental scientific studies elucidating the genetic pathways mediating outflow tract formation, provide insight into the etiology of congenital hydronephrosis, one of the most common congenital defects in humans. Results of these studies are likely to lead to novel therapies for the treatment of this condition and provide the groundwork for much-needed genetic tests that discriminate between fetal hydronephrotic syndromes that spontaneously resolve and those that result in permanent renal damage.
The author thanks Romulo Hurtado, Cindy Liang, and Cathy Mendelsohn for critically reading the manuscript and acknowledges NIH for full support of her research program (grants DK45218 and DK02723).
Conflict of interest: The author has declared that no conflict of interest exists.
Reference information: J Clin Invest. 2011;121(3):836–838. doi:10.1172/JCI46400
See the related article at GLI3 repressor controls functional development of the mouse ureter.